NO20032581D0 - Farmasöytisk formulering av gepiron for oral administrering - Google Patents

Farmasöytisk formulering av gepiron for oral administrering

Info

Publication number
NO20032581D0
NO20032581D0 NO20032581A NO20032581A NO20032581D0 NO 20032581 D0 NO20032581 D0 NO 20032581D0 NO 20032581 A NO20032581 A NO 20032581A NO 20032581 A NO20032581 A NO 20032581A NO 20032581 D0 NO20032581 D0 NO 20032581D0
Authority
NO
Norway
Prior art keywords
gepirone
oral administration
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
NO20032581A
Other languages
English (en)
Other versions
NO20032581L (no
Inventor
Johannes Gerardus Jos Egberink
John Francis Gelhart
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20032581D0 publication Critical patent/NO20032581D0/no
Publication of NO20032581L publication Critical patent/NO20032581L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
NO20032581A 2000-12-08 2003-06-06 Farmasöytisk formulering av gepiron for oral administrering NO20032581L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00204388 2000-12-08
PCT/EP2001/014189 WO2002045753A2 (en) 2000-12-08 2001-11-30 Oral extended release formulation of gepirone

Publications (2)

Publication Number Publication Date
NO20032581D0 true NO20032581D0 (no) 2003-06-06
NO20032581L NO20032581L (no) 2003-06-06

Family

ID=8172397

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032581A NO20032581L (no) 2000-12-08 2003-06-06 Farmasöytisk formulering av gepiron for oral administrering

Country Status (19)

Country Link
EP (1) EP1343504A2 (no)
JP (1) JP2004517083A (no)
KR (1) KR20040018314A (no)
CN (1) CN1479620A (no)
AR (1) AR031461A1 (no)
AU (1) AU2002226371A1 (no)
BR (1) BR0115976A (no)
CA (1) CA2436692A1 (no)
CZ (1) CZ20031589A3 (no)
EC (1) ECSP034627A (no)
HU (1) HUP0401021A2 (no)
IL (1) IL155855A0 (no)
MX (1) MXPA03005099A (no)
NO (1) NO20032581L (no)
PL (1) PL362445A1 (no)
RU (1) RU2003120446A (no)
SK (1) SK6942003A3 (no)
WO (1) WO2002045753A2 (no)
ZA (1) ZA200303915B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004028507A1 (en) * 2002-09-24 2004-04-08 Akzo Nobel N.V. Method to improve pharmaceutical tablets having a matrix of cellulose ether
EP1809255A4 (en) * 2004-11-05 2011-08-03 Fabre Kramer Holdings Inc HIGH DOSAGE FORMULATION OF GEPIRON WITH EXTENDED RELEASE
EP3657966A1 (en) * 2017-07-26 2020-06-03 Abbott Laboratories Nutritional tablets and methods of making the same
CN109745323A (zh) * 2017-11-01 2019-05-14 四川科瑞德制药股份有限公司 氮哌酮类化合物提高副交感神经活性的用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478572A (en) * 1994-09-06 1995-12-26 Bristol-Myers Squibb Co. Gepirone dosage form

Also Published As

Publication number Publication date
WO2002045753A3 (en) 2002-08-29
RU2003120446A (ru) 2005-02-20
AU2002226371A1 (en) 2002-06-18
JP2004517083A (ja) 2004-06-10
BR0115976A (pt) 2003-12-30
MXPA03005099A (es) 2004-02-12
CN1479620A (zh) 2004-03-03
SK6942003A3 (en) 2003-10-07
EP1343504A2 (en) 2003-09-17
IL155855A0 (en) 2003-12-23
WO2002045753A2 (en) 2002-06-13
ECSP034627A (es) 2004-09-28
CA2436692A1 (en) 2002-06-13
AR031461A1 (es) 2003-09-24
KR20040018314A (ko) 2004-03-03
PL362445A1 (en) 2004-11-02
ZA200303915B (en) 2004-08-20
CZ20031589A3 (cs) 2003-11-12
NO20032581L (no) 2003-06-06
HUP0401021A2 (hu) 2004-09-28

Similar Documents

Publication Publication Date Title
NO20033343D0 (no) Farmasöytiske doseringsformer av epothiloner for oral administrasjon
HUP0302319A3 (en) Pharmaceutical composition for oral administration of active ingredient
AU2002357012A1 (en) Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
NO20004823D0 (no) Nye galeniske formuleringer av meloksicam for oral administrering
DE60100186D1 (de) Orale pharmazeutische formulierungen von benzimidazolderivaten und verfahren zu ihrer herstellung
PL356358A1 (en) Solid dosage form of someticone for oral administration
NO20020976L (no) Retarderte, orale, farmasöytiske administreringsformer
AU2002216701A1 (en) Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
ATE298571T1 (de) Flüssige pharmazeutische formulierungen mit verbesserter oraler veträglichkeit
NO20020208D0 (no) Flytende sammensetninger for oral administrasjon
NO20042565L (no) Orale farmasoytiske produkter inneholdende 17 beta-ostradiol-3-lavere alkanoat, fremgangsmater for administrering av disse og fremgangsmater for fremstilling derav
NO20014035D0 (no) System for oral administrasjon av medikament
DE60317803D1 (de) Pharmazeutische zusammensetzungen enthaltend cyclosporin zur oralen verabreichung
DE60322454D1 (de) Pharmazeutische Zusammensetzungen zur oralen und topischen Verabreichung
NO20014738L (no) Tolperisonholdig farmasöytisk preparat for oral administrering
FI20000780A (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
NO20040047L (no) Farmasoytisk formulering for intramuskulaer administrering av fulvestrant
IS6532A (is) Lyfjaform til stýrðrar losunar á síprófloxasíni með inntöku um munn einu sinni á dag
NO20032581D0 (no) Farmasöytisk formulering av gepiron for oral administrering
NO20043007L (no) Farmasoytisk suspensjon for oral administrering
ITMI992736A0 (it) Composizioni farmaceutiche per la somministrazione localizzata nel cav o orale di farmaci antiinfiammatori non stereoidei utili per la terapi
EE200100196A (et) a-tsüklodekstriinil põhinevad farmatseutilised kompositsioonid LH-RH analoogide peroraalseks manustamiseks
GB0014474D0 (en) Pharmaceutical formulation and manufacture of oral dosage units
DK1165081T3 (da) Fremgangsmåde til fremstilling af tolperisonholdige farmaceutiske præparater til oral indgivelse
HU0303147D0 (en) Pharmaceutical compositions for oral and topical administration

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application